An observational, multicentre study of cabazitaxel in patients with metastatic castration ‐resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

BJU International, EarlyView.

Source: BJU International - September 17, 2018 Category: Urology & Nephrology Authors: Joan Carles , Angelika Pichler , Hana Korunkova , Antoaneta Tomova , Marwan Ghosn , Fadi El Karak , Joseph Makdessi , Irina Koroleva , Gisoo Barnes , Denise Bury , Ayse Özatilgan , Simon Hitier , Jana Katolicka Source Type: research